The Centers for Medicare and Medicaid Services announced earlier this month that it was pushing back the deadline by which pharmaceutical companies must begin collecting data on the amount of money they spend on individual physicians to January 1, 2013. Under the CMS’s proposed Physician Payments Sunshine Act, which was included as section 6002 of the Affordable Care Act of 2010, drug manufacturers must disclose any single payments to physicians of $10 or more, or aggregate ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock thePrinter-friendly, you'll also gain access to exclusive premium content.

Already registered? here.